Can a video rehab program help COPD patients in the countryside?

NCT ID NCT07666854

Not yet recruiting Symptom relief Sponsor: Tel-Aviv Sourasky Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a 12-week remote group rehabilitation program, done via video calls and a smartphone app, can help COPD patients living in remote areas start and stick with rehab. It compares this approach to standard in-person rehab. The goal is to see if the remote option improves access, reduces symptoms, and boosts quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Tele-rehabilitation program (remote group exercise and breathing sessions via app)
What this could lead to: If successful, this could provide a practical way for COPD patients in remote areas to access pulmonary rehabilitation from home, improving their breathing, quality of life, and reducing hospital visits.
What could go wrong: This is a small, early-stage feasibility study. The remote format may not work for everyone, and results may not apply to all COPD patients. There is also a risk of technical issues or lack of personal supervision.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease COPD, severe early onset

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) PERIPHERAL REHABILITATION

Contacts and locations

Locations

Tel Aviv Sourasky Medical Center

Tel Aviv, 6423906, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.